SecBot SecBot

Ensuring Access to Lower-Cost Medicines for Seniors Act

S. 2129 Sen. James Lankford (R-OK) In committee
Bill text PDF
  1. Introduced Jun 22
  2. Committee Jun 22
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, Jun 22, 2023Next: Senate vote
1224d ago Jun 22, 2023: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
3companies, 5 filings
Subscribe to see spend
Member trades
5trades in the last 90 days
Subscribe to see who
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

3 companies
Companies by sector
Biotech & Pharma 3
Search all 3 companies, their asks and price moves Subscribe

Summary

Ensuring Access to Lower-Cost Medicines for Seniors Act

Full summary2 paragraphs

This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.

Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.

Library of Congress summary, Jun 22, 2023

Summary versions
  • Introduced in SenateJun 22, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.